Skip to main content
    B

    Bruker Corporation (BRKR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $60.62
    -0.97 (-1.57%)

    Market Cap: $9.41B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bruker Corporation (BRKR) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Bruker (BRKR) to earn $2.14 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.54B. Of 13 analysts, 6 rate the stock Buy or Strong Buy, 6 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.54, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 46% of the ratings.

    RatingAnalystsShare
    Strong Buy17.7%
    Buy538.5%
    Hold646.2%
    Sell17.7%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    13

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 14.5% and revenue estimates rise 4.2%.

    Fiscal year ending Dec 31, 2026
    $2.14
    EPS consensus, revenue $3.54B
    Fiscal year ending Dec 31, 2027
    $2.45
    EPS consensus, revenue $3.69B
    Next report
    Feb 10, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.14$2.10 to $2.2113$3.54B$3.52B to $3.55B12
    Dec 31, 2027$2.45$2.36 to $2.7113$3.69B$3.65B to $3.74B12

    Quarterly Estimates

    The EPS consensus falls from $0.80 for the quarter ending Dec 31, 2026 to $0.44 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.80$0.74 to $0.9614$1.03B$969.17M to $1.08B14
    Mar 31, 2027$0.44$0.33 to $0.549$856.42M$846.20M to $874.03M7

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 8 upward and 3 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202662
    Quarter ending Mar 31, 202721

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.9% from $2.12.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.14$2.12$2.12$2.12$2.12+0.7%
    Fiscal year ending Dec 31, 2027$2.45$2.40$2.41$2.39$2.41+1.9%
    Quarter ending Mar 31, 2027$0.44$0.42$0.42$0.44$0.44+0.6%

    Frequently Asked Questions About BRKR

    What is the BRKR stock forecast?

    Consensus analyst estimates put Bruker's EPS at $2.14 for the fiscal year ending Dec 31, 2026, on revenue of $3.54B. The consensus rating from 13 analysts is Hold.

    How do analysts rate BRKR stock?

    Of 13 analysts covering Bruker, 1 rates it Strong Buy, 5 Buy, 6 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from BRKR next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.14, with estimates from $2.10 to $2.21 from 13 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.45, with estimates from $2.36 to $2.71 from 13 analysts.

    What revenue do analysts expect from Bruker next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.54B, with estimates from $3.52B to $3.55B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.69B, with estimates from $3.65B to $3.74B.

    How many analysts cover BRKR?

    13 analysts rate Bruker stock, and 13 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.